With rapid progress being made in our understanding of epigenetic mechanisms of both new and existing drugs, this SELECTBIO meeting, Epigenetics in Drug Discovery, will explore the potential of epigenetics contribution towards novel and existing therapeutics, across significant areas of unmet need. Emerging technologies, epigenetic changes and cellular reprogramming will be discussed, with special attention to drug discovery and development. Attendees will benefit from expert knowledge of academic and industry leaders pushing the boundaries of epigenetics research, whilst networking with the technology providers who are enabling them to do so.
Confirmed Keynote Speaker:
Rabinder Prinjha, Vice President, GlaxoSmithKline
You can present your research on a poster while attending the meeting. Poster Submission Deadline: 19 January 2016.
Contact for more information:
Tel: +44 (0) 1787 314956